| Issue |
Section |
Title |
File |
| Vol 8, No 8 (2022) |
Articles |
The structure of the prevalence of cardiovascular diseases and chronic kidney disease in patients with type 2 diabetes mellitus in the stationary care |
|
| Vol 8, No 8 (2022) |
Articles |
Chronic kidney disease and type 2 diabetes melitus: time determines the outcome |
|
| Vol 8, No 8 (2022) |
Articles |
Review of international clinical guidelines for diagnosis and treatment of late androgen deficiency in male patients |
|
| Vol 8, No 8 (2022) |
Articles |
Influence of dietary fiber on metabolism of gut microbiota and carbohydrate metabolism |
|
| No 4 (2015) |
Articles |
Uvazhaemye kollegi! |
|
| No 4 (2015) |
Articles |
EFFICACY AND SAFETY OF THE DPP-4 INHIBITOR SAXAGLIPTIN IN THE TREATMENT OF TYPE 2 DIABETES |
|
| No 4 (2015) |
Articles |
SHOULD SULFONYLUREAS REMAIN THE DRUGS OF FIRST CHOICE IN ADDITION TO METFORMIN? |
|
| No 4 (2016) |
Articles |
Empagliflozin: a new era in the treatment of diabetes mellitus type 2 |
|
| No 4 (2016) |
Articles |
Modern facilities and future prospects in pharmacotherapy of obesity |
|
| No 4 (2016) |
Articles |
Influence of fenofibrate on dyslipidemia and diabetic polyneuropathy in patients with diabetes mellitus type 2 |
|
| No 4 (2016) |
Articles |
Sulfonylurea derivatives in the light of evidence-based medicine and algorithms of diabetes mellitus type 2 |
|
| No 2 (2017) |
Articles |
Metformin: review of current evidence and international recommendations |
|
| No 6 (2016) |
Articles |
Oral hypoglycemic therapy in the practice of a general practitioner |
|
| No 3 (2016) |
Articles |
THE ROLE OF GLIMEPIRIDE IN THE MODERN COMBINED HYPOGLYCEMIC THERAPY OF DIABETES MELLITUS TYPE 2 |
|
| No 5 (2017) |
Articles |
Targets and modern strategy of therapy for different groups of patients with type 2 diabetes mellitus |
|
| No 5 (2017) |
Articles |
Acromegaly in practice of clinician: modern aspects of diagnosis and treatment |
|
| No 5 (2017) |
Articles |
Addisonian crisis as debut of primary chronic adrenocortical insufficiency |
|
| No 5 (2017) |
Articles |
Graves’ disease in clinical practice of a therapist |
|
| No 5 (2017) |
Articles |
Type 2 diabetes mellitus and cardiovascular diseases. Therapy that changes prognosis |
|
| No 5 (2018) |
Articles |
Modern capacities of the control of early carbohydrate metabolism disorders |
|
| No 5 (2018) |
Articles |
Causes of decompensation of 1 type diabetes mellitus in hospitalized to reanimation and intensive care department patients |
|
| No 5 (2018) |
Articles |
Estimation of practical value of physical symptoms of extremity ischemia in diabetes mellitus patients |
|
| No 5 (2018) |
Articles |
Aspects of hypercorticism diagnostics and treatment in therapeutical practice |
|
| No 5 (2018) |
Articles |
News of clinical recommendations on diagnostics and treatment of subclinical hypothyroidism in pregnant women |
|
| No 5 (2018) |
Articles |
Metabolic disorders in case of androgen deprivation: the role of endocrinologist in the management of the case |
|
| No 5 (2018) |
Articles |
Clinical case of primary hyperparathyroidism |
|
| Vol 9, No 5 (2023) |
REVIEWS |
The role of self-monitoring of glycemia in the treatment of patients with type 2 diabetes mellitus and the achievement of the target level of carbohydrate metabolism |
|
| Vol 9, No 9 (2023) |
ORIGINAL STUDIES |
Clinical and metabolic peculiarities in male patients with type 2 diabetes mellitus and hypogonadism |
|
| Vol 9, No 9 (2023) |
ORIGINAL STUDIES |
Possibilities of early diagnosis of chronic heart failure and chronic kidney disease in patients with type 2 diabetes mellitus at the hospital stage |
|
| Vol 9, No 9 (2023) |
ORIGINAL STUDIES |
Peculiarities of outpatient glycemic profile of patients with type 2 diabetes mellitus during innovative sugar-reducing therapy combined with metformin according to flash glucose monitoring data |
|
| Vol 9, No 9 (2023) |
REVIEWS |
The role and place of dipeptidyl peptidase-4 inhibitors in modern approaches to the management of type 2 diabetes mellitus |
|
| Vol 11, No 3 (2025) |
CLINICAL CASES |
Rapid course of severe diabetic retinopathy |
|
| Vol 11, No 3 (2025) |
REVIEWS |
Sodium-glucose cotransporter type 2 inhibitors: revolution in chronic heart failure treatment |
|
| Vol 11, No 3 (2025) |
LECTURES |
Modern concepts of pleiotropic effects of semaglutide in a wide population of patients |
|
